These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34240826)

  • 1. The association between Annexin A2 and epithelial cell adhesion molecule in breast cancer cells.
    Al-Qahtani SM; Gadalla SE; Guo M; Ericsson C; Hägerstrand D; Nistér M
    Cancer Rep (Hoboken); 2022 May; 5(5):e1498. PubMed ID: 34240826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCL18 promotes the invasion and metastasis of breast cancer through Annexin A2.
    Zhao C; Zheng S; Yan Z; Deng Z; Wang R; Zhang B
    Oncol Rep; 2020 Feb; 43(2):571-580. PubMed ID: 31894281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MIEN1, a novel interactor of Annexin A2, promotes tumor cell migration by enhancing AnxA2 cell surface expression.
    Kpetemey M; Dasgupta S; Rajendiran S; Das S; Gibbs LD; Shetty P; Gryczynski Z; Vishwanatha JK
    Mol Cancer; 2015 Aug; 14():156. PubMed ID: 26272794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted Nanocurcumin Therapy Using Annexin A2 Anitbody Improves Tumor Accumulation and Therapeutic Efficacy Against Highly Metastatic Breast Cancer.
    Mukerjee A; Ranjan AP; Vishwanatha JK
    J Biomed Nanotechnol; 2016 Jul; 12(7):1374-92. PubMed ID: 29336533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cell density on the malignant biological behavior of breast cancer by altering the subcellular localization of ANXA2 and its clinical implications.
    Chen J; Su X; Tan Q; Pu H; Zhang L; Kang Y; Tang Y; Zhao X; Hou W; Qian S; Deng S; Hou L; Gao Y
    Clin Transl Oncol; 2022 Nov; 24(11):2136-2145. PubMed ID: 35778647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rack1 mediates tyrosine phosphorylation of Anxa2 by Src and promotes invasion and metastasis in drug-resistant breast cancer cells.
    Fan Y; Si W; Ji W; Wang Z; Gao Z; Tian R; Song W; Zhang H; Niu R; Zhang F
    Breast Cancer Res; 2019 May; 21(1):66. PubMed ID: 31113450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deglycosylation of epithelial cell adhesion molecule affects epithelial to mesenchymal transition in breast cancer cells.
    Liu X; Yang L; Zhang D; Liu T; Yan Q; Yang X
    J Cell Physiol; 2019 Apr; 234(4):4504-4514. PubMed ID: 30246502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of triple-negative and Herceptin-resistant breast cancer cell proliferation and migration by Annexin A2 antibodies.
    Chaudhary P; Thamake SI; Shetty P; Vishwanatha JK
    Br J Cancer; 2014 Dec; 111(12):2328-41. PubMed ID: 25321192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyr23 phosphorylation of Anxa2 enhances STAT3 activation and promotes proliferation and invasion of breast cancer cells.
    Yuan J; Yang Y; Gao Z; Wang Z; Ji W; Song W; Zhang F; Niu R
    Breast Cancer Res Treat; 2017 Jul; 164(2):327-340. PubMed ID: 28470457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenesis-associated protein annexin II in breast cancer: selective expression in invasive breast cancer and contribution to tumor invasion and progression.
    Sharma MR; Koltowski L; Ownbey RT; Tuszynski GP; Sharma MC
    Exp Mol Pathol; 2006 Oct; 81(2):146-56. PubMed ID: 16643892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer cell surface annexin II induces cell migration and neoangiogenesis via tPA dependent plasmin generation.
    Sharma M; Ownbey RT; Sharma MC
    Exp Mol Pathol; 2010 Apr; 88(2):278-86. PubMed ID: 20079732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotype-dependent effects of EpCAM expression on growth and invasion of human breast cancer cell lines.
    Martowicz A; Spizzo G; Gastl G; Untergasser G
    BMC Cancer; 2012 Oct; 12():501. PubMed ID: 23110550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship Between Circulating Tumor Cells and Annexin A2 in Early Breast Cancer Patients.
    Bystricky B; Cierna Z; Sieberova G; Janega P; Karaba M; Minarik G; Benca J; Sedlackova T; Jurisova S; Gronesova P; Pindak D; Macuch J; Mardiak J; Mego M
    Anticancer Res; 2017 May; 37(5):2727-2734. PubMed ID: 28476852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of EpCAM overexpression on human breast cancer cell lines.
    Gostner JM; Fong D; Wrulich OA; Lehne F; Zitt M; Hermann M; Krobitsch S; Martowicz A; Gastl G; Spizzo G
    BMC Cancer; 2011 Jan; 11():45. PubMed ID: 21281469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of cytokeratin 18 induces cellular partial EMT and stemness through increasing EpCAM expression in breast cancer.
    Shi R; Liu L; Wang F; He Y; Niu Y; Wang C; Zhang X; Zhang X; Zhang H; Chen M; Wang Y
    Cell Signal; 2020 Dec; 76():109810. PubMed ID: 33069797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue plasminogen activator induces pancreatic cancer cell proliferation by a non-catalytic mechanism that requires extracellular signal-regulated kinase 1/2 activation through epidermal growth factor receptor and annexin A2.
    Ortiz-Zapater E; Peiró S; Roda O; Corominas JM; Aguilar S; Ampurdanés C; Real FX; Navarro P
    Am J Pathol; 2007 May; 170(5):1573-84. PubMed ID: 17456763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-directed neutralization of annexin II (ANX II) inhibits neoangiogenesis and human breast tumor growth in a xenograft model.
    Sharma M; Blackman MR; Sharma MC
    Exp Mol Pathol; 2012 Feb; 92(1):175-84. PubMed ID: 22044461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyrosine 23 phosphorylation-dependent cell-surface localization of annexin A2 is required for invasion and metastases of pancreatic cancer.
    Zheng L; Foley K; Huang L; Leubner A; Mo G; Olino K; Edil BH; Mizuma M; Sharma R; Le DT; Anders RA; Illei PB; Van Eyk JE; Maitra A; Laheru D; Jaffee EM
    PLoS One; 2011 Apr; 6(4):e19390. PubMed ID: 21572519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell surface interaction of annexin A2 and galectin-3 modulates epidermal growth factor receptor signaling in Her-2 negative breast cancer cells.
    Shetty P; Bargale A; Patil BR; Mohan R; Dinesh US; Vishwanatha JK; Gai PB; Patil VS; Amsavardani TS
    Mol Cell Biochem; 2016 Jan; 411(1-2):221-33. PubMed ID: 26438086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reciprocal regulation of annexin A2 and EGFR with Her-2 in Her-2 negative and herceptin-resistant breast cancer.
    Shetty PK; Thamake SI; Biswas S; Johansson SL; Vishwanatha JK
    PLoS One; 2012; 7(9):e44299. PubMed ID: 22957061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.